Evaluates coagulation responses in bonobos, suggesting unique health insights for management.
INTRODUCTION: Bonobos (Pan paniscus) are endangered and uncommon in managed care. Prothrombotic and hypofibrinolytic states are encountered with cardiovascular disease, ischemic stroke, and neoplasia. MATERIALS AND METHODS: Twelve bonobos from one institution were evaluated during anesthetized exams. Samples were analyzed on a VCM Vet analyzer, obtaining results within 1 h. RESULTS: VCM parameters (median [IQR]) reflected clot formation: clot time 300 s [265-332], clot formation time 97 s [82-107], α-angle 65° [63-69]; clot strength: maximum clot formation 50 units [47-52], amplitude 10 min 40 units [35-44], and amplitude 20 min 47 units [43-51]; and clot lysis: index 30 min 99.97% [99.95-100.00] and index 45 min 98.10% [97.50-99.20]. VCM was compared to thromboelastography and coagulation testing. DISCUSSION: Bonobos were hypercoagulable when compared to canine reference intervals, consistent with chimpanzees. Bonobos medicated for hypertension in this study were hypocoagulable compared to normotensive individuals.
No takes yet. Share an insight, caveat, or question.
Roeder et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: